We are live on ! Find out more
WGSWW

GeneDx Holdings Warrant

Delisted

WGSWW was delisted on the 21st of July, 2026.

25 hedge funds and large institutions have $27.4M invested in GeneDx Holdings Warrant in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

11% less funds holding

Funds holding: 2825 (-3)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

63% less capital invested

Capital invested by funds: $73.7M → $27.4M (-$46.3M)

Holders
25
Holders Change
-3
Holders Change %
-10.71%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
5
Reduced
4
Closed
7
Calls
$985K
Puts
Net Calls
+$985K
Net Calls Change
-$124K

WGSWW Hedge Fund Activity: Q2 2021 in Review

25 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings Warrant (WGSWW) for Q2 2021, worth a combined $27.4M — down 63% from $73.7M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of WGSWW and 4 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 5 added.

The largest buyer was Ionic Capital Management, adding an estimated $593K. The largest seller was SB Management, exiting entirely with an estimated $37.2M sold.

  • 25 institutional investors held GeneDx Holdings Warrant (WGSWW) as of Q2 2021, down from 28 in Q1 2021.
  • Funds reported $27.4M of GeneDx Holdings Warrant stock for Q2 2021, down 63% quarter-over-quarter.
  • 4 funds opened new GeneDx Holdings Warrant positions in Q2 2021 and 7 closed out, a net change of -3 holders.
  • The largest GeneDx Holdings Warrant buyer in Q2 2021 was Ionic Capital Management, an estimated $593K added.
  • The largest GeneDx Holdings Warrant seller in Q2 2021 was SB Management, an estimated $37.2M sold.

Based on aggregated 13F filings for Q2 2021.